Is Sorafenib an Optimal Treatment for Hepatocellular Carcinoma With Macrovascular Invasion or Metastatic Disease?

Hepatology - United States
doi 10.1002/hep.29862
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley